Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
FAT jabs could be the cancer hope of the future after early studies found they reduce the risk of tumours. The world’s top ...
The Simulation VIP is ready-made for your environment, providing consistent results whether you are using Incisive®, Synopsys VCS®, or Mentor Questa® simulators. You have the freedom to ... The I2C ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...
A low-calorie sweetener called xylitol used in many reduced-sugar foods and consumer products such as gum and toothpaste may ...
New research suggests statins may reduce heart disease risk and increase longevity in adults 75 and older, challenging ...
The UK is one of the heaviest nations in Europe now with 63.8 per cent of the population overweight or obese, and one in four ...
Study adds to evidence that semaglutide, also known by the brand names Ozempic or Wegovy, can be used for a range of chronic conditions ...
Novo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes ...
Discover how Novo Nordisk's Ozempic and Wegovy reduce the risk of major kidney disease events, heart problems, and death in patients with diabetes.
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people ...
Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major ...